Artificial pancreas clinical trials: Moving towards closed-loop control using insulin-on-board constraints
Artificial pancreas (AP) systems for people with type 1 diabetes (T1DM) combine the use of a smart insulinpump with a Continuous Glucose Monitor (CGM) and a control algorithm to improve the regulation ofglycaemia. Based on the extensive clinical evidence provided by the main research groups in the a...
Guardado en:
| Autores principales: | Fushimi, Emilia, Rosales, Nicolás, De Battista, Hernán, Garelli, Fabricio |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/149290 |
| Aporte de: |
Ejemplares similares
-
Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses
por: Sánchez Peña, Ricardo, et al.
Publicado: (2018) -
Automatic glycemic regulation for the pediatric population based on switched control and time-varying IOB constraints: an in silico study
por: Fushimi, Emilia, et al.
Publicado: (2020) -
Artificial Pancreas: Evaluating the ARG Algorithm Without Meal Announcement
por: Fushimi, Emilia, et al.
Publicado: (2019) -
Artificial Pancreas: First Clinical Trials in Argentina
por: Sánchez Peña, R., et al.
Publicado: (2017) -
Artificial pancreas under stable pulsatile MPC: Improving the closed-loop performance
por: Abuin, Pablo, et al.
Publicado: (2021)